Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy [Phase 1]
Phase 1 clinical trial sponsored by the University of Alabama at Birmingham evaluating UAB 2419-CD34 selection using the CliniMACS Prodigy s…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial) [Phase 2]
Phase 2 ERASE trial update exploring combination therapy for persistent low-level acute myeloid leukemia after initial treatment; the study …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating adaptive dual-target CAR-T cell therapy for relapsed or refractory hematologic malignancies; recru…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy) [Phase 2]
Clinical trial update outlining plans to study IDH1 inhibitor olutasidenib in combination with ASTX727 and venetoclax for acute myeloid leuk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial update evaluating the addition of navtemadlin to standard cytarabine and idarubicin in patients with acute myeloid le…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML [Phase 1]
Phase 1 trial update testing the combination of iadademstat with venetoclax and azacitidine for acute myeloid leukemia is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts [Phase 1]
Phase 1 clinical trial evaluating TAK-243 for relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes with increased bla…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial is testing KRT-232 (AMG-232) in combination with Decitabine and Venetoclax for Acute Myeloid Leukemia. The study is…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes [Phase 1]
Phase 1 clinical trial update indicating GLB-001 is being studied in relapsed or refractory Acute Myeloid Leukemia and relapsed or refractor…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms [Phase 1]
This is a Phase 1 clinical-trial update for JNJ-90189892 in relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasms, curr…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating L-Annamycin for Injection in combination with cytarabine as second-line remission induction therapy…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Prospective collection, storage, and reporting of data on patients undergoing hematopoietic stem cell transplantation using a standard prepa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms [Phase 1]
Phase 1 clinical trial update announcing JNJ-89853413 for relapsed or refractory acute myeloid leukemia and myelodysplastic neoplasms, curre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies [Phase 1]
A Phase 1 study is evaluating ICP-248 in combination with azacitidine for myeloid malignancies, including acute myeloid leukemia and myelody…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation [NA]
This entry notes a clinical trial exploring an eHealth mindfulness-based music therapy intervention for patients undergoing stem cell transp…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
A Phase 1/2 study of CTX-712 in relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syndromes is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A multicenter protocol to improve access and distribution of unlicensed cryopreserved cord blood units, with the study currently recruiting.…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: VAH vs VA in Newly Diagnosed Elderly AML [Phase 3]
Phase 3 clinical trial comparing VAH versus VA in newly diagnosed elderly patients with acute myeloid leukemia; the study status is not yet …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML [Phase 3]
Phase 3 clinical trial updating a study of Ziftomenib in combination with venetoclax and azacitidine or standard 7+3 induction for newly dia…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: ABC Maintenance Therapy for AML [NA]
A clinical trial update indicates a not-yet-recruiting study of ABC Maintenance Therapy for acute myeloid leukemia in remission.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Motixafortide for MRD Sensitization in AML [Phase 2]
A Phase 2 clinical trial of motixafortide for sensitizing measurable residual disease in acute myeloid leukemia is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia [Phase 1]
Phase 1 trial evaluating the combination of atezolizumab with allogeneic natural killer cell therapy in adults with relapsed or refractory a…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) [Phase 1]
Genmab announced a first-in-human Phase 1 trial of GEN3018 in relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syn…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial evaluating BMS-986497 (ORM-6151) as monotherapy and in dual/triple combinations with azacitidine and venetoclax in re…